The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $37.49

Today's change-0.80 -2.09%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $37.49

Today's change-0.80 -2.09%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.

Baxter International Inc down (U.S.)$0.80

Baxter International Inc closed sharply lower Friday, dropping (U.S.)$0.80 or 2.09% to (U.S.)$37.49. Over the last five days, shares have gained 2.43%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 38.62% during the last year.

Key company metrics

  • Open(U.S.) $38.10
  • Previous close(U.S.) $38.29
  • High(U.S.) $38.30
  • Low(U.S.) $37.26
  • Bid / Ask-- / --
  • YTD % change-1.73%
  • Volume5,029,537
  • Average volume (10-day)6,407,886
  • Average volume (1-month)5,726,623
  • Average volume (3-month)5,241,124
  • 52-week range(U.S.) $32.18 to (U.S.) $72.84
  • Beta0.65
  • Trailing P/E51.48×
  • P/E 1 year forward24.89×
  • Forward PEG2.26×
  • Indicated annual dividend(U.S.) $0.46
  • Dividend yield1.23%
  • Trailing EPS(U.S.) $0.73
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.01%

Based on its net profit margin of 4.01%, Baxter International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue2,4873,8933,7644,472
Total other revenue--------
Total revenue2,4873,8933,7644,472
Gross profit1,0491,9261,7952,202
Total cost of revenue1,4381,9671,9692,270
Total operating expense2,5253,4583,2783,725
Selling / general / administrative670951887970
Research & development140292298305
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)277248124180
Other operating expenses, total--------
Operating income-38435486747
Interest income (expense), net non-operating-38-40-35-36
Gain (loss) on sale of assets--------
Other--------
Income before tax-33468530598
Income after tax2336420524
Income tax, total-3513211074
Net income1332430953
Total adjustments to net income--------
Net income before extra. items2336420524
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2336420524
Inc. avail. to common incl. extra. items1332430953
Diluted net income1332430953
Dilution adjustment--------
Diluted weighted average shares549549548547
Diluted EPS excluding extraordinary itemsvalue per share0.000.610.770.96
Dividends per sharevalue per share0.120.520.520.52
Diluted normalized EPSvalue per share0.341.000.911.25